K05 K05.3
Conditions
Interventions
Group 1: clinical cohort study
observation of oral hygiene after giving oral hygiene instructions utilizing a display model and a hand mirror as a visualization tool (control group).
Recruiting period: approx. 1 year.
The test sub
observation of oral hygiene after giving oral hygiene instructions utilizing an intraoral scan as a visualization tool (test group).
Recruiting period: approx. 1 year.
The test subjects are anonymize
Sponsors
Universitätsklinikum Schleswig-Holstein Campus Kiel
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Written consent to participate in the study, · generalized periodontitis = Stage I · be in good general health · have at least 10 healthy teeth (not severely decayed) · agree not to participate in any other clinical studies on oral care during the duration of this study · agree not to undergo any additional professional teeth cleaning outside of the therapy sessions during ATG/MHU or AIT for the duration of the study · agree to follow the study procedures and attend all scheduled clinical visits · agree to refrain from elective dental treatments such as teeth whitening, orthodontic tooth movements, etc., that are not part of the study protocol during the study
Exclusion criteria
Exclusion criteria: Lack of patient consent to student treatment during the anti-infective therapy phase · Currently participating in or having participated in another clinical study on oral care within the last 30 days · Dentists or dental students, dental assistants · a disease, condition, or state that is expected to interfere with the examination procedures or could influence or prevent the safe conduct of the study (e.g., chemotherapy, epilepsy, AIDS, diabetes mellitus with HbA1c above 7.5) · physical limitations that could prevent normal oral hygiene · Self-reported pregnancy or breastfeeding · Use of medications for at least three consecutive days within the last 28 days that could influence the results of the study (e.g., anti-inflammatory drugs, Dilantin, NSAIDs such as ibuprofen) · current use of medications that may cause gum overgrowth (e.g., calcium antagonists such as nifedepine, hydantoin, ciclosporin) · a known allergic reaction to any of the test substances or other allergic reactions to dental materials or oral hygiene products · need medication of any kind prior to dental procedures · show signs of major hard or soft tissue lesions or trauma or carious lesions requiring restorative treatment · are undergoing active orthodontic treatment · are heavy smokers (more than 10 cigarettes/day)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| reduction of the plaque control record (?PCR mod. O’Leary) examination evaluation approx. 3-4 month after finishing periodontal treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| Reduction of probing depth, reduction of bleeding on probing (BOP), reduction of gingival bleeding index (GBI) | — |
Countries
Germany
Contacts
Public ContactMiriam Cyris
Universitätsklinikum Schleswig-Holstein, Campus Kiel Klinik für Zahnerhaltungskunde und Parodontologie
Outcome results
None listed